Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Treasury Shares: 2021-2025

Historic Treasury Shares for Fennec Pharmaceuticals (FENC) over the last 4 years, with Sep 2025 value amounting to $419,000.

  • Fennec Pharmaceuticals' Treasury Shares rose 14.17% to $419,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $419,000, marking a year-over-year increase of 14.17%. This contributed to the annual value of $324,000 for FY2024, which is 48.62% up from last year.
  • Fennec Pharmaceuticals' Treasury Shares amounted to $419,000 in Q3 2025, which was down 13.61% from $485,000 recorded in Q2 2025.
  • Fennec Pharmaceuticals' Treasury Shares' 5-year high stood at $589,000 during Q1 2025, with a 5-year trough of $35,000 in Q4 2022.
  • In the last 3 years, Fennec Pharmaceuticals' Treasury Shares had a median value of $367,000 in 2024 and averaged $363,182.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 522.86% in 2023, then dropped by 28.19% in 2024.
  • Fennec Pharmaceuticals' Treasury Shares (Quarterly) stood at $55,000 in 2021, then spiked by 87.27% to $35,000 in 2022, then skyrocketed by 522.86% to $218,000 in 2023, then spiked by 48.62% to $324,000 in 2024, then rose by 14.17% to $419,000 in 2025.
  • Its Treasury Shares stands at $419,000 for Q3 2025, versus $485,000 for Q2 2025 and $589,000 for Q1 2025.